Lilly (LLY) Shows Incremental Growth Opportunities - Piper Jaffray
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Eli Lilly & Co. (LLY), Merck (MRK) Enter Collaboration for Abemaciclib Phase 1
December 10, 2015 6:31 AM ESTEli Lilly and Company (NYSE: LLY) and Merck (NYSE: MRK) announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck's KEYTRUDA® (pembrolizumab) in a Phase I study across multiple tumor types. Based on the Phase I trial results, the collaboration has the potential to progress to Phase II trials in patients who have been diagnosed with either metastatic breast... More
BMO Capital Incrementally Positive on Lilly's (LLY) Alzheimer’s Disease Pipeline Update; Maintains at 'Outperform'
December 8, 2015 2:14 PM ESTBMO Capital is incrementally positive on Eli Lilly & Co. (NYSE: LLY) following an update on the company's Alzheimers disease (AD) pipeline. BMO rates Lilly at Outperform with a price target of $100.
Analyst Alex Arfaei summarized:
Based on our initial review of the slides,... More
Eli Lilly & Co. (LLY) Raises Quarterly Dividend 2% to $0.51; 2.4% Yield
December 8, 2015 7:15 AM ESTEli Lilly & Co. (NYSE: LLY) declared a quarterly dividend of $0.51 per share, or $2.04 annualized. This is a 2% increase from the prior dividend of $0.50.
The dividend will be payable on March 10, 2016, to stockholders of record on February 12, 2016, with an ex-dividend date of February 10,... More
Deutsche Bank Upgrades Eli Lilly (LLY) to Buy
December 7, 2015 6:34 AM ESTDeutsche Bank upgraded Eli Lilly (NYSE: LLY) from Hold to Buy with a price target of $99.00 (from $85.00). Analyst Gregg Gilbert expects investors interest in Sola to grow, and he pointed out that Jardiance is gaining steam.
"We are raising our peak... More
